As previously reported, Goldman Sachs analyst Robert Cox downgraded Travelers (TRV) to Neutral from Buy with a price target of $304, up from $302. Travelers exclusively writes P&C lines, with an overweight exposure to property and personal insurance exposures relative to peers, notes the analyst, who expects the insurer to report peer-low organic premium growth of about 2.5% and more material core margin compression between 2026 and 2027 amid a softening P&C market. The firm also highlights “particularly meaningful competition” in the Personal Auto and Commercial Property lines.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRV:
- Travelers downgraded to Neutral from Buy at Goldman Sachs
- Travelers price target raised to $317 from $309 at Evercore ISI
- Travelers price target raised to $305 from $302 at JPMorgan
- Travelers price target raised to $317 from $305 at Keefe Bruyette
- Travelers price target lowered to $262 from $265 at BofA